marketcaparena
Search

    DARE

    Dare Bioscience, Inc.

    Company overview

    Market capitalization
    $11.47M
    Employees
    21
    Latest publication
    2026-09-29
    About Dare Bioscience, Inc.

    Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1 and DARE-PTB1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB2 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue187,546USD152,455USD1,023,676USD2,262USD-21,172USD25,427USD-63,647USD41,691USD
    Cost Of Revenue319,889USD796,968USD295,799USD612,864USD0USD2,297,381USD14,222,534USD25,000USD
    Gross Profit-132,343USD-644,513USD727,877USD2,262USD-21,172USD-2,271,954USD-14,286,181USD16,691USD
    Research Development241,966USD152,455USD622,041USD1,175,168USD1,428,762USD2,297,381USD3,311,142USD2,656,772USD
    Selling General Administrative2,593,671USD2,248,566USD1,577,104USD2,499,242USD2,377,866USD1,943,164USD1,781,082USD1,847,268USD
    Total Operating Expenses2,835,637USD2,354,385USD2,199,145USD3,674,410USD3,806,628USD2,309,164USD-8,897,984USD4,698,040USD
    Operating Income-2,967,980USD-2,998,898USD-1,471,268USD-3,672,148USD-3,827,800USD-4,581,118USD-5,388,197USD-4,681,349USD
    Total Other Income Expense Net-14,793USD-991USD29,550USD109,382USD-188,683USD202,811USD-118,201USD-21,152USD
    Net Income-2,982,773USD-2,999,889USD-1,441,718USD-3,562,766USD-4,016,483USD-4,378,307USD-5,506,398USD-4,702,501USD
    Interest Expense—199,394USD206,955USD213,171USD268,533USD———
    Income Before Tax—-2,999,889USD-1,441,718USD-3,562,766USD-4,016,483USD-4,378,307USD-5,506,398USD-4,702,501USD
    Net Income From Continuing Ops—-2,999,889USD-1,441,718USD-3,562,766USD-4,016,483USD-4,378,307USD-5,506,398USD-4,702,501USD
    Ebit—-2,998,898USD-1,471,268USD-3,672,148USD-3,827,800USD-4,581,118USD-5,388,197USD-4,681,349USD
    Ebitda—-2,444,255USD-936,873USD-3,190,242USD-3,367,725USD-4,423,008USD-5,381,829USD-4,671,607USD
    Depreciation And Amortization—554,643USD534,395USD481,906USD460,075USD158,110USD6,368USD9,742USD
    Reconciled Depreciation—554,643USD534,395USD481,906USD460,075USD158,110USD6,368USD9,742USD
    Unclassified Operating Expenses—————-1,931,381USD-13,990,208USD—
    Income Tax Expense——————-2USD—
    Selling And Marketing Expenses———————194,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,030,193USD9,784USD2,807,885USD10,000,000USD10,000,000USD0USD0USD0USD
    Cost Of Revenue2,447,180USD14,305,208USD21,638,074USD47,617USD100,000USD83,333USD11,137USD625,000USD
    Gross Profit-1,416,987USD-14,295,424USD-18,830,189USD10,000,000USD-100,000USD-83,333USD-11,137USD-2,440USD
    Research Development5,523,352,000USD14,205,208USD21,538,074USD30,042,217USD30,617,567USD20,769,416USD8,546,108USD6,414,000USD
    Selling General Administrative8,763,376USD8,356,061USD11,309,691USD11,243,271USD7,789,945USD6,114,508USD5,799,000USD5,281,000USD
    Unclassified Operating Expenses-5,519,980,029USD-13,405,208USD-20,738,074USD—————
    Total Operating Expenses12,135,347USD9,156,061USD12,109,691USD41,385,488USD38,968,512USD27,318,924USD14,333,743USD11,695,000USD
    Operating Income-13,552,334USD-23,451,485USD-30,939,880USD-31,385,488USD-39,068,512USD-27,402,257USD-14,344,880USD-16,882,000USD
    Interest Expense822,709USD——437,750,000USD372,407USD0USD0USD0USD
    Income Before Tax-13,399,274USD-4,053,599USD-30,161,391USD-30,947,738USD-38,696,105USD-27,400,743USD-14,263,830USD-16,739,000USD
    Net Income-13,399,274USD-4,053,599USD-30,161,391USD406,802,262USD-38,696,105USD-27,400,743USD-14,263,830USD-16,739,000USD
    Net Income From Continuing Ops-13,399,274USD-4,053,599USD-41,047,052USD-30,947,738USD-38,696,105USD-27,400,743USD-14,263,830USD-16,738,815USD
    Ebit-13,552,334USD-23,451,485USD-30,739,880USD-31,385,488USD-39,068,512USD-27,402,257USD-14,263,830USD-11,694,440USD
    Ebitda-11,400,953USD-23,409,160USD-30,701,517USD-31,361,286USD-39,042,099USD-27,359,030USD-14,252,693USD-11,692,000USD
    Depreciation And Amortization2,151,381USD42,325USD38,363USD24,202USD26,413USD43,227USD11,137USD2,440USD
    Reconciled Depreciation1,634,486USD42,325USD39,005USD24,202USD26,413USD43,227USD11,137USD2,440USD
    Total Other Income Expense Net153,060USD19,397,886USD778,489USD437,750USD372,407USD1,514USD81,050USD143,497,000USD
    Income Tax Expense—-4,049,545,401USD-3USD-437,750,000USD-370,000USD-163,000USD-161,000USD10,232,000USD
    Selling And Marketing Expenses———600,000USD560,999USD435,000USD223,000USD—
    Net Income Applicable To Common Shares———-30,947,738USD-38,696,105USD-27,407,606USD-15,053,424USD-16,738,815USD
    Non Operating Income Net Other—————1,514USD81,050USD143,497USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets22,370,109USD27,828,414USD32,474,563USD30,748,574USD12,979,525USD18,618,941USD22,101,131USD18,058,801USD
    Cash And Equivalents12,617,594USD———————
    Total Current Assets16,686,163USD21,659,137USD27,063,879USD25,004,180USD6,602,417USD11,822,549USD18,447,863USD14,946,271USD
    Other Current Assets456,429USD2,851,597USD1,779,462USD1,559,762USD1,379,295USD1,387,348USD2,519,707USD3,194,776USD
    Other Non Current Assets2,554,166USD———————
    Total Liabilities22,930,209USD———————
    Total Current Liabilities16,922,620USD21,119,013USD23,685,687USD21,216,394USD19,221,143USD21,188,074USD21,609,013USD13,155,725USD
    Other Current Liabilities448,945USD———————
    Total Stockholder Equity-560,100USD734,451USD2,842,634USD2,857,903USD-12,733,260USD-9,563,701USD-6,012,089USD-1,484,483USD
    Total Equity Including Noncontrolling Interest-560,100USD———————
    Property Plant Equipment Net2,257,392USD3,726,827USD4,401,245USD4,726,021USD5,307,206USD5,717,865USD2,542,674USD2,034,089USD
    Accounts Payable762,914USD1,231,086USD1,200,686USD1,844,862USD1,762,600USD1,883,142USD1,455,832USD1,048,679USD
    Short Term Debt594,493USD1,208,143USD2,096,654USD2,478,794USD2,420,095USD2,319,397USD548,638USD505,824USD
    Common Stock1,517USD1,456USD1,450USD1,393USD903USD885USD870USD854USD
    Retained Earnings-194,671,566USD-191,688,793USD-188,688,904USD-187,247,186USD-183,684,420USD-179,667,937USD-175,289,630USD-169,783,232USD
    Accumulated Other Comprehensive Income-374,856USD-377,081USD-421,623USD-395,966USD-402,826USD-415,719USD-428,809USD-362,625USD
    Total Liab—27,093,963USD29,631,929USD27,890,671USD25,712,785USD28,182,642USD28,113,220USD19,543,284USD
    Other Current Liab—529,325USD736,895USD2,335,473USD2,711,569USD1,863,573USD3,042,918USD1,850,862USD
    Capital Stock—2,112USD1,450USD1,393USD903USD885USD870USD854USD
    Cash—18,519,784USD24,711,356USD23,075,261USD5,035,006USD10,329,967USD15,698,174USD11,232,609USD
    Cash And Short Term Investments—18,519,784USD24,711,356USD23,075,261USD5,035,006USD10,329,967USD15,698,174USD11,232,609USD
    Current Deferred Revenue—18,150,459USD19,651,452USD14,557,265USD12,326,879USD15,121,962USD16,561,625USD9,750,360USD
    Net Debt—-11,336,691USD-22,055,337USD-20,142,715USD-2,002,293USD-2,016,002USD-14,395,153USD-5,339,226USD
    Short Long Term Debt Total—7,183,093USD2,656,019USD2,932,546USD3,032,713USD8,313,965USD1,303,021USD5,893,383USD
    Net Receivables—287,756USD573,061USD369,157USD188,116USD105,234USD229,982USD518,886USD
    Property Plant Equipment Gross—3,726,827USD4,739,258USD4,726,021USD5,307,206USD5,717,865USD2,718,568USD2,034,089USD
    Common Stock Shares Outstanding—14,522,835shares14,499,502shares12,755,112shares8,871,155shares8,759,000shares8,497,000shares8,534,000shares
    Non Current Assets Total—6,169,276USD5,410,684USD5,744,394USD6,377,108USD6,796,392USD3,653,268USD3,112,530USD
    Non Current Liabilities Total—5,974,950USD5,946,242USD6,674,277USD6,491,642USD6,994,568USD6,504,207USD6,387,559USD
    Non Current Liabilities Other—5,556,697USD5,386,877USD5,220,525USD4,879,024USD4,741,338USD4,749,824USD4,489,769USD
    Non Currrent Assets Other—2,142,449USD1,009,439USD1,018,373USD1,069,902USD778,527USD1,110,594USD778,441USD
    Net Working Capital—540,124USD3,378,192USD3,787,786USD-12,618,726USD-9,365,525USD-3,161,150USD1,790,546USD
    Unclassified Equity—192,796,757USD191,950,261USD190,498,269USD171,352,180USD170,518,185USD169,704,610USD168,659,666USD
    Unclassified Non Current Liabilities———1,453,752USD1,612,618USD2,253,230USD1,754,383USD1,897,790USD
    Short Term Investments——————15,682,475,826USD—
    Unclassified Current Assets——————-15,682,475,826USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets32,474,563USD22,101,131USD21,282,215USD43,826,383USD55,807,177USD7,550,712USD7,442,788USD7,827,387USD
    Other Current Assets1,779,462USD2,519,707USD6,118,272USD6,665,988USD2,476,612USD1,854,277USD1,108,615USD403,097USD
    Total Liab29,631,929USD28,113,220USD26,329,855USD32,714,273USD17,052,856USD8,702,445USD7,001,962USD1,100,767USD
    Total Stockholder Equity2,842,634USD-6,012,089USD-5,047,640USD11,112,110USD38,754,321USD-1,151,733USD440,826USD6,726,620USD
    Other Current Liab736,895USD3,042,918USD2,889,005USD10,894,016USD3,136,244USD4,359,718USD2,098,653USD631,351USD
    Common Stock1,450USD870USD9,997USD8,482USD8,394USD4,159USD1,968USD1,143USD
    Capital Stock1,450USD870USD9,997USD8,482USD8,394USD4,159USD1,968USD1,143USD
    Retained Earnings-188,688,904USD-175,289,630USD-171,236,031USD-141,074,640USD-110,126,902USD-71,430,797USD-44,023,191USD-28,969,767USD
    Cash24,711,356USD15,698,174USD10,476,056USD34,669,605USD51,674,087USD4,669,467USD4,780,107USD6,805,889USD
    Cash And Short Term Investments24,711,356USD15,698,174USD10,476,056USD34,669,605USD51,674,087USD4,669,467USD4,780,107USD6,805,889USD
    Total Current Assets27,063,879USD18,447,863USD17,543,539USD43,038,753USD55,296,016USD6,983,912USD6,443,932USD7,240,023USD
    Total Current Liabilities23,685,687USD21,609,013USD20,480,436USD31,623,927USD16,052,856USD7,660,601USD5,612,406USD1,091,056USD
    Current Deferred Revenue19,651,452USD16,561,625USD13,737,154USD18,303,567USD10,542,983USD1,564,553USD2,019,674USD—
    Net Debt-22,055,337USD-14,395,153USD-9,071,587USD-34,180,868USD-51,403,541USD-3,912,626USD-3,979,655USD-6,805,889USD
    Short Term Debt2,096,654USD548,638USD468,726USD398,391USD270,546USD714,997USD410,896USD—
    Short Long Term Debt Total2,656,019USD1,303,021USD1,404,469USD488,737USD270,546USD756,841USD800,452USD—
    Net Receivables573,061USD229,982USD949,211USD1,703,160USD1,145,317USD460,168USD555,210USD31,037USD
    Accounts Payable1,200,686USD1,455,832USD3,385,551USD2,027,953USD2,103,083USD1,021,333USD1,083,183USD459,705USD
    Property Plant Equipment Net4,401,245USD2,542,674USD1,975,605USD522,833USD242,714USD277,480USD551,811USD9,396USD
    Property Plant Equipment Gross4,739,258USD2,718,568USD1,975,605USD522,833USD242,714USD37,930USD551,811USD9,396USD
    Accumulated Other Comprehensive Income-421,623USD-428,809USD-360,896USD-351,311USD-154,973USD-91,388USD-102,625USD-96,728USD
    Common Stock Shares Outstanding111,787,520shares8,497,000shares7,275,000shares7,048,000shares5,096,000shares2,508,000shares1,298,000shares894,368shares
    Non Current Assets Total5,410,684USD3,653,268USD3,738,676USD787,630USD511,161USD566,800USD998,856USD587,364USD
    Non Current Liabilities Total5,946,242USD6,504,207USD5,849,419USD1,090,346USD1,000,000USD1,041,844USD1,389,556USD9,711USD
    Non Current Liabilities Other5,386,877USD4,749,824USD3,913,676USD——1,041,844USD1,389,556USD—
    Non Currrent Assets Other1,009,439USD1,110,594USD1,428,071USD264,797USD268,447USD289,320USD447,045USD577,968USD
    Net Working Capital3,378,192USD-3,161,150USD-2,936,897USD11,414,826USD39,243,160USD-676,689USD831,526USD6,148,967USD
    Unclassified Equity191,950,261USD169,704,610USD166,529,293USD152,521,097USD149,019,408USD70,362,134USD44,562,706USD35,790,829USD
    Other Assets—1USD——268,447USD528,870USD447,045USD577,968USD
    Short Term Investments—15,682,475,826USD——————
    Unclassified Current Assets—-15,682,475,826USD——————
    Unclassified Non Current Liabilities—1,754,383USD1,935,743USD1,090,346USD————
    Net Tangible Assets———26,343,772USD38,754,321USD-1,151,733USD440,826USD6,726,620USD
    Deferred Long Term Liab————143,002USD——9,711USD
    Other Liab————1,000,000USD1,000,000USD1,000,000USD9,711USD
    Inventory————-2,474,135,388USD-1,852,422,723USD-1,107,506,385USD-402,693,903USD
    Short Long Term Debt—————367,285USD——
    Good Will———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation1,126,786USD
    Stock Based Compensation741,666USD
    Change To Account Receivables3,194USD
    Change To Liabilities-93,718USD
    Change In Working Capital-1,748,171USD
    Operating Cash Flow-12,295,690USD
    Capital Expenditures-80,586USD
    Investing Cash Flow-80,586USD
    Net Debt Issuance-1,344,727USD
    Unclassified Financing Cash Flow1,580,474USD
    Financing Cash Flow235,747USD
    Effect Of Forex Changes On Cash46,767USD
    Change In Cash-12,093,762USD
    End Cash Flow12,917,594USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-2,999,889USD-1,441,718USD-3,562,766USD-4,016,483USD-4,378,307USD-5,506,398USD-4,702,501USD12,910,656USD
    Depreciation554,643USD669,041USD612,864USD460,075USD158,110USD6,368USD9,742USD15,437USD
    Stock Based Compensation455,064USD357,160USD403,027USD359,018USD377,357USD489,260USD523,578USD562,718USD
    Other Non Cash Items140,425USD114,255USD589,382USD255,744USD128,301USD245,841USD162,134USD199,093USD
    Change To Account Receivables-114,695USD-203,904USD-181,041USD-82,882USD124,748USD288,904USD383,288USD483,498USD
    Change In Working Capital-3,670,887USD2,102,686USD1,918,385USD-2,475,810USD-1,756,004USD9,991,539USD-1,917,039USD-783,219USD
    Total Cash From Operating Activities-5,520,644USD1,444,264USD-442,135USD-5,417,456USD-5,470,543USD5,226,610USD-5,924,086USD12,904,685USD
    Capital Expenditures-4USD-206,644USD-174,705USD-153,396USD-157,331USD-562,849USD-282,326USD-285,226USD
    Free Cash Flow-5,520,644USD1,237,620USD-616,840USD-5,264,060USD-5,627,874USD4,663,761USD-5,641,760USD12,619,459USD
    Net Borrowings-1,079,070USD-529,008USD-93,810USD-521,257USD-187,221USD-187,221USD436,849USD—
    Total Cash From Financing Activities-715,470USD424,129USD18,650,232USD-43,794USD246,577USD-132,012USD436,444USD115,366USD
    Issuance Of Capital Stock392,100USD1,274,823USD18,744,042USD475,013USD436,248USD55,488USD0USD182,978USD
    Change In Cash-6,191,572USD1,636,095USD18,040,255USD-5,294,961USD-5,368,207USD4,465,565USD-5,182,383USD12,749,389USD
    Begin Period Cash Flow25,011,356USD23,075,261USD5,035,006USD10,629,967USD15,998,174USD11,532,609USD16,414,992USD3,965,603USD
    End Period Cash Flow18,819,784USD24,711,356USD23,075,261USD5,335,006USD10,629,967USD15,998,174USD11,232,609USD16,714,992USD
    Other Cashflows From Financing Activities-28,500USD-1,264,188USD18,650,232USD2,450USD-2,450USD-279USD-405USD-815USD
    Total Cashflows From Investing Activities—-206,641USD-174,702USD153,396USD-157,331USD-562,849USD282,325USD-285,226USD
    Investments——-174,702USD153,396USD-157,331USD-562,849USD282,325USD-285,226USD
    Unclassified Financing Cash Flow——-18,650,232USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-13,399,274,000USD-4,053,599USD-30,161,391USD-30,947,738USD-38,696,105USD-27,400,743USD-14,263,830USD-16,738,815USD
    Depreciation1,634,486,000USD42,325USD38,363USD24,202USD26,413USD43,227USD11,137USD2,440USD
    Stock Based Compensation1,496,562,000USD2,203,256USD2,530,684USD2,158,511USD1,599,692USD742,031USD462,239USD139,348USD
    Other Non Cash Items382,566,743USD1,388,523USD-837,417USD-23,062USD-421,733USD-162,167USD-231,217USD5,694,519USD
    Change To Account Receivables-343,079USD719,229USD753,948USD-557,842USD-685,149USD95,042USD-201,423USD253,168USD
    Change In Working Capital-210,743USD5,813,742USD-10,426,893USD10,699,658USD8,727,696USD1,542,728USD706,191USD634,083USD
    Total Cash From Operating Activities-9,885,870,000USD5,394,247USD-38,856,654USD-18,088,429USD-28,764,037USD-25,234,924USD-13,315,480USD-10,268,425USD
    Capital Expenditures-385,278,000USD-573,046USD-629,430USD-63,069USD-14,524USD-17,625USD-17,625USD-11,836USD
    Free Cash Flow-10,271,148,000USD4,821,201USD-39,486,084USD-18,151,498USD-28,778,561USD-25,252,549USD-13,315,480USD-10,280,261USD
    Total Cashflows From Investing Activities-385,278,000USD-573,046USD-629,430USD-63,069USD-14,524USD-17,625USD6,143,893USD-518,836USD
    Net Borrowings-1,331,296USD-17,560USD267,189USD0USD0USD367,285USD367,285USD367,285USD
    Total Cash From Financing Activities19,277,144,000USD433,830USD15,637,120USD1,343,354USD75,846,766USD25,130,672USD5,151,702USD10,111,952USD
    Issuance Of Capital Stock20,930,126USD453,579USD8,560,897USD1,218,750USD75,314,091USD22,977,407USD5,151,702USD10,111,952USD
    Change In Cash9,013,182,000USD5,187,118USD-23,858,549USD-17,004,482USD47,004,620USD-110,640USD-2,025,782USD-753,957USD
    Begin Period Cash Flow15,998,174,000USD10,811,056USD34,669,605USD51,674,087USD4,669,467USD4,780,107USD6,805,889USD7,559,846USD
    End Period Cash Flow25,011,356,000USD15,998,174USD10,811,056USD34,669,605USD51,674,087USD4,669,467USD4,780,107USD6,805,889USD
    Other Cashflows From Financing Activities19,256,602,668USD-2,189USD6,023,275USD124,604USD532,675USD9,016,265USD789,594,000USD2USD
    Investments—-573,046USD-24,796USD-63,069USD-14,524USD-17,625USD6,143,893USD-518,836USD
    Other Cashflows From Investing Activities—-572,472,954USD—-925,000,000USD-925,000,000USD—6,143,893USD-507,000USD
    Unclassified Investing Cash Flow—573,046,000USD—925,063,069USD925,014,524USD—-6,126,268USD—
    Change To Inventory———557,842USD685,149USD-95,042USD201,423USD—
    Change To Liabilities———0USD10,060,179USD483,029USD1,230,268USD124,403USD
    Dividends Paid—————-6,863,000USD-789,594,000USD—
    Sale Purchase Of Stock—————24,763,387USD5,151,702USD10,111,952USD
    Cash And Cash Equivalents Changes—————-121,877USD-2,019,885USD-753,957USD
    Unclassified Financing Cash Flow—————-2,153,265USD——
    Exchange Rate Changes———————-78,648USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2024Quarterly · 2024-09-30ProductLicense0USD0001401914-24-000041
    Q3 2024Quarterly · 2024-09-30ProductRoyalty41,691USD0001401914-24-000041
    FY 2023Yearly · 2023-12-31ProductLicense1,000,000USD0001401914-25-000012
    FY 2023Yearly · 2023-12-31ProductMilestone Revenue1,800,000USD0001401914-25-000012
    FY 2023Yearly · 2023-12-31ProductRoyalty7,885USD0001401914-25-000012
    Q3 2023Quarterly · 2023-09-30ProductLicense1,000,000USD0001401914-24-000041
    Q3 2023Quarterly · 2023-09-30ProductRoyalty0USD0001401914-24-000041
    FY 2022Yearly · 2022-12-31ProductLicense10,000,000USD0001401914-24-000016
    FY 2022Yearly · 2022-12-31ProductMilestone Revenue0USD0001401914-24-000016
    FY 2022Yearly · 2022-12-31ProductRoyalty0USD0001401914-24-000016

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.